Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vectus Biosystems Limited ( (AU:VBS) ) has provided an update.
Vectus Biosystems Limited has released its annual financial report, which includes consolidated financial statements and notes. The report, authorized by the Board of Directors, reflects the company’s financial activities and performance in Australian dollars, providing stakeholders with insights into its fiscal health and strategic direction.
More about Vectus Biosystems Limited
Vectus Biosystems Limited is a publicly listed company based in Australia, operating in the biotechnology industry. It focuses on developing therapeutic products and solutions, with a market emphasis on addressing fibrotic diseases and hypertension.
Average Trading Volume: 54,692
Technical Sentiment Signal: Sell
Current Market Cap: A$3.2M
For a thorough assessment of VBS stock, go to TipRanks’ Stock Analysis page.